Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen.
Moons
P
P
Center for Health Services and Nursing Research, Katholieke Universiteit Leuven, Kapucijnenvoer 35/4, B-3000 Leuven, Belgium.
Vanrenterghem
Y
Y
van Hooff
J P
JP
Squifflet
J P
JP
Margodt
D
D
Mullens
M
M
Thevissen
I
I
De Geest
S
S
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D001294:Attitude to Health; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005260:Female; D006304:Health Status; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011788:Quality of Life; D016559:Tacrolimus / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016559:Tacrolimus